Scopus Eşleşmesi Bulundu
7
Atıf
203
Cilt
Özet
The methanolic and water extracts of Carapa procera leaves and stem barks were screened for their phytochemical content using a multi-technique approach. The extracts were also assessed for their in vitro antioxidant capacity along with their anti-diabetic (α-amylase, α-glucosidase), anti-tyrosinase, anti-elastase and anti-cholinesterase (AChE, BChE) activities. Furthermore, antibacterial and antifungal effects were determined against several bacterial and fungal strains. Data Integration Analysis for Biomarker discovery using Latent components (DIABLO) integrative analysis was conducted on collected data to determine the influence of extraction solvents and plant parts on phytochemical content, antioxidant properties and enzyme inhibitory properties of C. procera samples. Additionally, the major identified compounds were screened as modulators of multiple pathways involved in human diseases via Gene Ontology (GO) enrichment analysis. Results showed that methanolic stem bark extract exhibited the most potent ABTS scavenging, Cu2+ and Fe3+ reducing power, total antioxidant capacity and Fe2+ chelating power and displayed the highest total flavanol content. Methanolic extracts of leaves and stem barks were abounded with phenolics and had the greatest anti-AChE, anti-BChE, anti-tyrosinase and anti-elastase activities. A significant antifungal activity was observed, with the lowest minimum inhibitory concentration and minimum fungicidal values of 0.07 and 0.15 mg/mL, respectively. DIABLO integrative analysis suggested that the phytochemical content and biological activities varied significantly within the plant parts and were influenced by types of solvent used. GO enrichment analysis on the main bioactive compounds showed modulation of multiple pathways associated with cancer. Obtained results demonstrated that stem bark and leaves of C. procera can be considered as promising sources of bioactive molecules with high pharmacological values.
Havuzumuzdaki Atıflar 0
Bu makaleye, sistemimizdeki Scopus veritabanında bulunan 0 makale atıf yapmıştır. Scopus genel atıf sayısı: 7.
Bu makaleye, kendi Scopus havuzumuzdaki başka bir makaleden atıf kaydı bulunmuyor.
Scimago Dergi Bilgisi
Otomatik ISSN Eşleştirmesi
2021 yılı verileri
Journal of Pharmaceutical and Biomedical Analysis
Q2
SJR Quartile
0,657
SJR Skoru
154
H-Index
Kategoriler: Analytical Chemistry (Q2) · Clinical Biochemistry (Q2) · Drug Discovery (Q2) · Pharmaceutical Science (Q2) · Spectroscopy (Q2)
Alanlar: Biochemistry, Genetics and Molecular Biology · Chemistry · Pharmacology, Toxicology and Pharmaceutics
Ülke: Netherlands
· Elsevier B.V.
Bu bilgiler makale yılına göre Scimago veritabanından ISSN eşleştirmesiyle otomatik getirilmektedir.
Dergi sıralama verileri Scimago'nun ilgili yılı baz alınmaktadır.
Anahtar Kelimeler
Bu makale için anahtar kelime bilgisi bulunmuyor.
Makale Bilgileri
Dergi
Journal of Pharmaceutical and Biomedical Analysis
ISSN
0731-7085
Yıl
2021
/ 1. ay
Cilt / Sayı
203
Makale Türü
Özgün Makale
Hakemlik
Hakemli
Endeks
SCI-Expanded
JCR Quartile
Q2
Teşvik Puanı
16,00
· YÖKSİS Akademik Teşvik
Yayın Dili
Türkçe
Kapsam
Uluslararası
Toplam Yazar
9 kişi
Erişim Türü
Elektronik
Alan
Fen Bilimleri ve Matematik Temel Alanı
Biyoloji
Biyokimya
Hayvan Fizyolojisi-Ekofizyolojisi
YÖKSİS Yazar Kaydı
Yazar Adı
Sinan Kouadio Ibrahime, Ferrarese Irene, AKTÜMSEK ABDURRAHMAN, Peron Gregorio, Glamocilja Jasmina, Sokovic Marina, Nenadić Marija, Dall’Acqua Stefano, ZENGİN GÖKHAN
YÖKSİS ID
6112471